Skip to main content
Signal8

CK Life Sciences Intl (Holdings) Inc

SEC insider (Form 3/4/5 filer). CIK 0001297567. Director & 10% Owner at Dogwood Therapeutics, Inc. (DWTX). 1 reported Form 4/5 transaction since Sep 2024; latest on Mar 12, 2025. Located in NEW TERRITORIES, K3.

Companies CK Life Sciences Intl (Holdings) Inc has filed insider reports for

  • Dogwood Therapeutics, Inc. (DWTX): Director, 10% Owner
CK Life Sciences Intl (Holdings) Inc profile photo

CK Life Sciences Intl (Holdings) Inc

CIK: 0001297567

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Dogwood Therapeutics, Inc. logo
DWTX

Dogwood Therapeutics, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Dogwood Therapeutics, Inc. logo
    DWTX

    Dogwood Therapeutics, Inc.

    Mar 12, 2025
    Award

    Series A-1 Preferred Stock

    Indirect
    284 shares at avg. $7.01-

1-1 of 1